CrossrefInfokarte
Transitioning Therapeutic Antibodies in Oncology from Intravenous to Hyaluronidase-Facilitated Subcutaneous Administration
Clinical Pharmacokinetics · 2026-09 · 65 (9) · 1277-1294
DOI: 10.1007/s40262-026-01669-7 ↗Abstract
Kein Abstract verfügbar.
EUVIMED